LIFETECH SCI (01302) announced its annual results for the period ending December 31, 2025. The company reported revenue of RMB1.37 billion, representing an increase of approximately 5.1% compared to the previous year. However, profit attributable to shareholders was RMB148 million, a decrease of 33.53% year-on-year. Basic earnings per share stood at 3.4 fen. According to the announcement, the growth in revenue was primarily driven by increased sales of covered stents.